Sees FY24 gross margin 53%-54%. Sees FY24 free cash flow $1.7B-$2B. Sees FY24 tax rate 14%-17%. Reiterates FY27 revenue growth view up mid-single digits. Reiterates FY27 operating income margin 30%. Guidance taken from Q1 earnings conference call.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEVA:
- Options Volatility and Implied Earnings Moves Today, May 08, 2024
- Options Volatility and Implied Earnings Moves This Week, May 06 – May 10, 2024
- Teva Pharmaceutical Industries Limited (TEVA) Q1 Earnings Cheat Sheet
- Teva call volume above normal and directionally bullish
- FTC expands patent listing challenges for drugs
